Ignite Creation Date:
2025-12-24 @ 7:11 PM
Ignite Modification Date:
2026-02-26 @ 11:05 AM
Study NCT ID:
NCT05418803
Status:
COMPLETED
Last Update Posted:
2022-06-16
First Post:
2022-06-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
BE Study of Two Formulations of Rivaroxaban 2.5 mg in Healthy Subjects
Sponsor:
Yuhan Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-01-28
Start Date Type:
ACTUAL
Primary Completion Date:
2020-02-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-14
Completion Date Type:
ACTUAL
First Submit Date:
2022-06-09
First Submit QC Date:
None
Study First Post Date:
2022-06-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-13
Last Update Post Date:
2022-06-16
Last Update Post Date Type:
ACTUAL